초록접수 현황

16F-257 구연 발표

Comparison of the Results of Hybrid Coronary Revascularization and Conventional Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease
Do Youn Kim, Won Jung Cho, Kun Hyun Jo, Whan Wook Kim, Hyun Song, Joonkyu Kang
Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary’s Hospital, The Catholic University College of Medicine, Seoul, Korea

Background : Convetional CABG is standard treatment of multivessel disease and hybrid coronary revascularization has beed developed with new generation drug eluting stent and minimally invasive surgery. We compare the early and mid-term results of hybrid coronary revascularization(HCR) and conventional coronary artery bypass graft (cCABG).

Methods : Each of 88 cases of HCR and cCABG cases between May, 2010 and August, 2016, were studied retrospectively after matched with the variables of age, gender and preoperative left ventricular ejection fraction. Various postoperative factors including in-hospital and mid-term mortality, development of in-hospital and postoperative major adverse cerebrovascular or cardiac events(MACCE) rates, and repeated revascularization were analysed.

Results : Mean age, ratio of gender and mean left ventricular ejection fraction were not statistically different. Rate of reoperation due to postoperative bleeding was 1.1% of all group. Hybrid coronary revascularization was associated with lower need for blood transfusion, shorter length of stay, and lower need for pain blocker. There was no in-hospital mortality in HCR group and 1.1% in cCABG group, which was not statistically different. There was one case of stroke only in HCR group. Mean follow up duration was 34 months and no differences between two groups in mid-term mortality, postoperative MACCE and repeated revascularization(p = 0.08) was found.

Conclusion : Hybrid coronary revascularization is associated with lower transfusion and earlier recovery. In development of complication and survival at early and mid-term postoperative period, and repeated revascularization, there was no differences between two groups. Long-term follow up and randomized trial must be warranted.


책임저자: Joonkyu Kang
Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary’s Hospital, The Catholic University College of Medicine, Seoul, Korea
발표자: Joonkyu Kang, E-mail : jkkang@catholic.ac.kr

수 정